Zinzino AB Reports Strong Third Quarter Revenue Growth

GOTHENBURG, Sweden, Oct. 5, 2026 /CourierPR/ -- Zinzino AB, a leading company in the global market, reported a strong performance in the third quarter of 2026. The group's revenue surged by 18% compared to the same period last year, reaching SEK 928.2 million. This growth was driven by a 15% increase in sales markets, which amounted to SEK 917.3 million in September 2026. Faun Pharma's external sales also saw an improvement, increasing to SEK 6.4 million from SEK 3.7 million.

The overall revenue for the Group increased by 16% to SEK 317.3 million in the third quarter, reflecting a robust financial performance. Accumulated revenue for the first nine months of 2026 reached SEK 2,787.1 million, marking a 21% rise from the same period in 2025.

Zinzino operates in diverse regions, including the Nordics, Central Europe, East Europe, South & West Europe, the Baltics, North America, South America, Asia-Pacific, and Africa. The company's diversified market presence contributed significantly to its overall growth. Notable regions such as the United Kingdom, Spain, and the United States saw substantial increases in sales, bolstering the company's global footprint.

These figures underscore Zinzino's strong financial health and its ability to capitalize on market opportunities. The company's diversified revenue streams and robust sales growth in key regions position it well for continued success in the global market.